Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)
NCT06319287
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Foot Ulcer
Interventions
BIOLOGICAL:
PEP (Purified Exosome Product) / TISSEEL
Sponsor
Rion Inc.
Collaborators
[object Object]